- Home
- CLNN vs DTIL Comparison
CLNN vs DTIL Comparison
Compare CLNN & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- DTIL
- Stock Information
- Founded
- CLNN 2012
- DTIL 2006
- Country
- CLNN United States
- DTIL United States
- Employees
- CLNN N/A
- DTIL N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- CLNN Health Care
- DTIL Health Care
- Exchange
- CLNN Nasdaq
- DTIL Nasdaq
- Market Cap
- CLNN 57.9M
- DTIL 55.3M
- IPO Year
- CLNN N/A
- DTIL 2019
- Fundamental
- Price
- CLNN $6.17
- DTIL $4.53
- Analyst Decision
- CLNN Strong Buy
- DTIL Strong Buy
- Analyst Count
- CLNN 6
- DTIL 2
- Target Price
- CLNN $32.67
- DTIL $47.00
- AVG Volume (30 Days)
- CLNN 117.0K
- DTIL 74.9K
- Earning Date
- CLNN 11-12-2025
- DTIL 11-03-2025
- Dividend Yield
- CLNN N/A
- DTIL N/A
- EPS Growth
- CLNN N/A
- DTIL N/A
- EPS
- CLNN N/A
- DTIL N/A
- Revenue
- CLNN $286,000.00
- DTIL $1,261,000.00
- Revenue This Year
- CLNN N/A
- DTIL N/A
- Revenue Next Year
- CLNN $2,178.18
- DTIL $135.19
- P/E Ratio
- CLNN N/A
- DTIL N/A
- Revenue Growth
- CLNN N/A
- DTIL N/A
- 52 Week Low
- CLNN $2.28
- DTIL $3.61
- 52 Week High
- CLNN $7.10
- DTIL $10.48
- Technical
- Relative Strength Index (RSI)
- CLNN 59.58
- DTIL 40.62
- Support Level
- CLNN $5.77
- DTIL $4.86
- Resistance Level
- CLNN $6.54
- DTIL $5.17
- Average True Range (ATR)
- CLNN 0.57
- DTIL 0.24
- MACD
- CLNN -0.04
- DTIL -0.06
- Stochastic Oscillator
- CLNN 53.03
- DTIL 4.48
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.